-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Unicycive Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2020 to Q3 2025.
- Unicycive Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 18.1M shares, a 103% increase year-over-year.
- Unicycive Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 67M shares, a 173% increase from 2023.
- Unicycive Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 24.5M shares, a 63% increase from 2022.
- Unicycive Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 15.1M shares, a 29% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)